The aim of the RRF pilot study grants program is to allow investigators to perform novel retina research that will result in preliminary data necessary for future applications to larger funding sources, including the NIH. The RRF pilot grants are awarded annually. If satisfactory progress on annual review is noted, grants may be renewed up to three times (for 3 years). RRF pilot grant awards are typically $25,000 – $50,000. The number and size of the grant awards varies each year depending on the RRF’s income from donations and investments.
Grant re-applications are subject to repeat review on an individual basis each year.
The completed application should convey how the grant will serve to further the purpose of your research project.
All pilot study grant applications for the 2027 grant period
are due by: Tuesday, August 18, 2026.
Grant applications will be reviewed by the RRF Grants Selection Committee and approved by the RRF Board of Directors. All applicants will be notified of grant decisions in mid-January 2027.
Topics: Retina research ONLY.
C. Grant budgets should include salaries, equipment and supplies. It is RRF policy not to fund the salary of the principal investigator(s). The following may not be included in budgets: travel expense, expenses related to publication of the research, and indirect costs.
D. Grants must be awarded for one year only. Applicants must re-apply for continued funding on an annual basis – such renewal applications will be considered in the light of progress made in the previous year. Researchers may propose a project plan to be implemented over a three-year grant period, and these longer range plans are encouraged. However, the initial application must include the aims and budget specifically in support of the initial year’s research planned. If you have plans for a three year study, you may include that information in an addendum to the application.
E. Budgets are usually limited to $25,000-$50,000 per grant unless supported by another funding source for a higher amount.
RRF's mission is explicitly focused on reducing retinal blindness. Projects that directly address retinal diseases, retinal degeneration, macular disorders, retinal vascular disease, retinal genetics, or vision preservation are most aligned with Foundation priorities.
The Foundation states that Pilot Study Grants are intended to "break new ground" and investigate new research directions. Successful proposals typically explore innovative hypotheses, emerging technologies, or novel disease mechanisms rather than incremental extensions of previous work.
One of the clearest published objectives of RRF funding is to support studies that produce preliminary data necessary for larger future grant applications, particularly NIH submissions. Applications that clearly explain how pilot findings will position investigators for subsequent funding have a strong advantage.
Competitive applications generally demonstrate:
Applications are reviewed by the RRF Grants Selection Committee, making scientific rigor a central consideration.
Historically funded programs and institutional awards frequently support translational retina research, ocular genomics, macular disease research, and vision science. Projects with a plausible path toward improving diagnosis, prevention, or treatment are likely to be viewed favorably.
RRF Pilot Study Grants are relatively modest awards (typically about $25,000–$50,000). Successful applications generally have focused aims, realistic timelines, and achievable objectives that can be completed within the pilot funding period.
Funded investigators frequently come from major vision-research institutions and demonstrate substantial expertise in retinal biology, ophthalmology, genetics, neuroscience, or vision science. Strong publication records and technical capability help strengthen applications.
Recent RRF-supported activities and institutional programs suggest strong interest in:
Projects within these themes often align closely with RRF's mission.
Because the Foundation's mission centers on reducing retinal blindness, projects with the potential to significantly improve understanding, prevention, or treatment of vision loss tend to be especially attractive.
Many award recipients come from leading ophthalmology departments, vision institutes, and academic medical centers. Access to specialized facilities, patient cohorts, imaging platforms, and collaborative expertise strengthens feasibility and reviewer confidence.
Based on RRF-funded programs and recipient institutions, frequently supported themes include:
A highly competitive Retina Research Foundation application typically includes:
Sponsor Institute/Organizations: Retina Research Foundation
Sponsor Type: Corporate/Non-Profit
Address: 3555 Timmons Lane, Suite 810 Houston, Texas 77027 713-797-1925
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Aug 18, 2026
Aug 18, 2026
$50,000
Affiliation: Retina Research Foundation
Address: 3555 Timmons Lane, Suite 810 Houston, Texas 77027 713-797-1925
Website URL: https://retinaresearchfnd.org/pilot-study-grants/grant-info/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.